Grazoprevir is a drug approved for the treatment of hepatitis C. Grazoprevir is a second-generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets.

1206524-86-8

C38H49KN6O9S

805

MK-5172;MK 5172 potassium;MK 5172;MK5172;Grazoprevir potassium;Grazoprevir;Grazoprevir potassium salt

DMSO:Soluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years